The ownership structure of GlobeImmune (GBIM) stock is a mix of institutional, retail and individual investors. Approximately 11.43% of the company’s stock is owned by Institutional Investors, 41.93% is owned by Insiders and 46.64% is owned by Public Companies and Individual Investors.
The ownership structure of GlobeImmune (GBIM) stock is a mix of institutional, retail and individual investors. Approximately 11.43% of the company’s stock is owned by Institutional Investors, 41.93% is owned by Insiders and 46.64% is owned by Public Companies and Individual Investors.
According to the latest TipRanks data, approximately 11.43% of the company's stock is held by institutional investors, 41.93% is held by insiders, and 46.64% is held by retail investors.
What percentage of GlobeImmune (GBIM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.43% of GlobeImmune (GBIM) stock is held by institutional investors.
What percentage of GlobeImmune (GBIM) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.64% of GlobeImmune (GBIM) stock is held by retail investors.
Who owns the most shares of GlobeImmune (GBIM)?
Edward Torres owns the most shares of GlobeImmune (GBIM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.